[go: up one dir, main page]

WO2009106399A1 - Produit de traitement capillaire comportant un extrait de canneberge - Google Patents

Produit de traitement capillaire comportant un extrait de canneberge Download PDF

Info

Publication number
WO2009106399A1
WO2009106399A1 PCT/EP2009/050923 EP2009050923W WO2009106399A1 WO 2009106399 A1 WO2009106399 A1 WO 2009106399A1 EP 2009050923 W EP2009050923 W EP 2009050923W WO 2009106399 A1 WO2009106399 A1 WO 2009106399A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic
hair
agent
preferred
compositions according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/050923
Other languages
German (de)
English (en)
Inventor
Marcus Krueger
Dieter Goddinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of WO2009106399A1 publication Critical patent/WO2009106399A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Definitions

  • the present invention relates to the cosmetic use of a cranberry extract for
  • a care complex should be provided, which can also be used in conjunction with oxidizing agent.
  • Fibers especially human hair, with the application of an effective fiber protection against environmental influences, such as UV protection, are connected.
  • Cranberry in the following cranberry extract, is dissolved.
  • Mossberry also called cranberry (Vaccinium macrocarpon).
  • a first subject of the present invention are therefore cosmetic agents for the treatment of keratinic fibers, in particular human hair, contained in a cosmetic
  • Carrier an extract from the fruits of Vaccinium macrocarpon (cranberry extract).
  • the cosmetic agents are used to treat keratinous fibers, in particular human hair.
  • Preferred agents according to the invention are therefore shampoos, conditioners or hair tonics.
  • the avivage can be significantly improved by using the cranberry extract. This manifests itself in an improvement in the combability, feel or shape of keratinous fibers, especially human hair.
  • combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber.
  • the measuring parameters can be sensory assessed by the skilled person or quantified by measuring devices.
  • the grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.
  • Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
  • keratinous fibers By maintaining the natural growth of keratinous fibers, it is understood that the effects on natural hair growth are compensated by hair cosmetic treatments as outlined above, in particular by oxidative hair treatments, and no or at least slight effects on the natural growth of the keratinic fibers in terms of thickness growth, the growth in length and / or in relation to the hair fullness are present.
  • the growth in thickness, the growth in length or the hair fullness can be determined both subjectively and objectively or in different test models.
  • an oxidative hair treatment the action of an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.
  • the cranberry extract is preferably used immediately before, during or after the oxidative hair treatment in the form of an agent containing a cranberry extract in a cosmetic carrier.
  • an application directly followed by the oxidative hair treatment wherein the cranberry extract-containing agent has previously been rinsed from the hair or preferably left on the hair and the hair is preferably still wet ,
  • an application following the oxidative hair treatment is understood as meaning after the oxidative hair treatment, wherein the agent containing a cranberry extract after rinsing the hair dye or the bleaching agent or the waving agent on the preferably still wet, towel-dried Hair is applied, or applied to dry or wet hair only after several hours or days.
  • the agent according to the invention can be rinsed out again after a contact time of a few seconds up to 45 minutes or remain completely on the hair.
  • the effect of the agent according to the invention unfolds even during the oxidative hair treatment and surprisingly persists even after intensive washing out of the composition according to the invention.
  • the cranberry extract is preferably used in a cosmetic carrier.
  • the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • An aqueous cosmetic carrier contains at least 50% by weight of water.
  • cosmetic carriers are aqueous solutions containing from 3 to 70% by weight of a C 1 -C 6 -alkyl alcohol, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, Iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6-hexanediol to understand.
  • the compositions of the invention may additionally contain other organic solvents, such as methoxybutanol,
  • a preferred suitable cranberry extract under the trade name Fruit Cranberry Liquid B ® from Crodarom distributed (INCI name (EU): glycerol, Water, Vaccinium Macrocarpon (Cranberry) Fruit Extract, 5.0-10.0 wt .-%. Active substance in Glycerin / Water).
  • the cosmetic compositions according to the invention contain the extracted substances from the fruits of the cranberry preferably in an amount of 0.0001 to 3.0 wt .-%, particularly preferably from 0.01 to 1, 0 wt .-%, most preferably from 0 , 05 to 0.5 wt .-%, each based on the weight of the ready-to-use agent.
  • the agents according to the invention also contain at least one further active ingredient.
  • this further active ingredient is selected from the group formed from L-carnitine tartrate, coenzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and their derivatives or physiologically acceptable salts.
  • betaines are betaines.
  • the betaines according to the invention are to be understood as meaning those which correspond to the formula (A-I).
  • betaines of the formula (AI) are: carnitine, carnitine tartrate, carnitine magnesium citrate, acetylcarnitine, taurine, taurine lysylate, taurine tartrate, taurine ornithine, lysyl taurine and ornithyl taurine, 1,1-dimethyl-proline, hercynine (N ', N ', N'-trimethyl-L-histidinium betaine), choline, choline chloride, choline bitartrate,
  • compositions according to the invention may contain both a compound according to formula (AI) and several, in particular two, compounds of formula (AI).
  • the active ingredient used is L-carnitine tartrate.
  • the cosmetic composition contains, in addition to the cranberry extract, taurine and / or at least one of its derivatives.
  • taurine is meant 2-aminoethanesulfonic acid.
  • Taurine derivatives are N-monomethyltaurine and N, N-dimethyltaurine. Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.
  • compositions of the invention contain biochinones which act as coenzymes.
  • suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
  • the preferred ubiquinones according to the invention have the following formula:
  • the cosmetic agent contains a combination of coenzyme Q-10 (ubiquinone-50) and / or at least one of its derivatives and cranberry extract.
  • the cosmetic composition contains a combination of ectoine ((S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid) and / or at least one of its derivatives and cranberry extract ,
  • the cosmetic composition contains a combination of pantolactone ((R) -dihydro-3-hydroxy-4,4-dimethyl-2 (3H-furanone) and cranberry extract
  • the cosmetic composition comprises a combination of pantothenic acid and / or at least one of its derivatives and cranberry extract Pantothenic acid is preferred as a derivative in the form of the more stable calcium salts and sodium salts (Ca-pantothenate
  • Other suitable pantothenic acid derivatives in the context of the present invention are panthenol and panthethein Particularly preferred according to the invention are agents which, based on their weight, have 0.00001 to
  • % preferably 0.0001 to 5.0 wt .-%, of the active ingredients from the group formed by Car nitintartrate, co-enzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and their derivatives.
  • compositions according to the invention may also contain carnitine tartrate, coenzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and / or derivatives thereof in the form of natural product extracts obtained from natural products containing the corresponding active ingredients or their derivatives. It may furthermore be particularly preferred if the agent according to the invention additionally contains at least one conditioning agent.
  • Preferred conditioning agents are selected from the group consisting of cationic surfactants, cationic polymers and silicones. Very particularly cationic polymers are used as further ingredients in the compositions according to the invention.
  • Preferred cationic polymers are commercially available and, for example, quaternized cellulose derivatives, cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of
  • Acrylic acid and methacrylic acid are Acrylic acid and methacrylic acid.
  • Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate such as vinylpyrrolidone quaternized with diethyl sulfate
  • Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers quaternized polyvinyl alcohol and those under the names Polyquaternium 2,
  • Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain
  • the cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • a last group of substances which can additionally be used as conditioning agents in the compositions according to the invention are silicone oils (in the following also silicones).
  • the conditioning agent is a conditioning silicone having a viscosity of from 20,000 to 120,000 mPa s, most preferably from 40,000 to 80,000 mPa s.
  • the conditioning silicone is particularly preferably selected from dimethicones, amodimethicones or dimethiconols.
  • the agent according to the invention may be used in the context of a color change of the hair.
  • the oxidative color change is preferred because the care effect of the compositions of the invention is excellent even in the presence of an oxidizing agent.
  • the cosmetic agents additionally preferably contain at least one color-modifying component.
  • the authenticity of the color obtained against environmental influences is improved.
  • the color-changing component is again preferably selected
  • the cosmetic agent therefore additionally contains at least one oxidation dye precursor of the developer component type.
  • the actual oxidative colorant is prepared by separate storage of the dye precursors and the oxidizing agent immediately before use by mixing.
  • the cosmetic agent is therefore mixed before application from a composition comprising at least one color-modifying component in a cosmetic carrier and a further composition containing at least one oxidizing agent in a cosmetic carrier.
  • the ready-to-use composition is conveniently prepared immediately prior to use by mixing a composition containing the oxidizing agent with the composition containing the color-changing components.
  • the resulting ready-to-use hair preparation should preferably have a pH in the range from 6 to 12, in particular from pH 7.5 to 10.
  • at least one bleaching booster is preferably used in the cosmetic compositions according to the invention.
  • Bleach boosters are preferably used in bleaching agents for increasing the bleaching action of the oxidizing agent, in particular the hydrogen peroxide.
  • the bleach boosters are present in the cosmetic agents according to the invention preferably in amounts of from 5 to 30% by weight, in particular in amounts of from 8 to 20% by weight.
  • the cosmetic agents of the invention when acting as a bleaching agent, contain as preferred alkalizing agent at least one compound selected from ammonium, alkali metal and alkaline earth metal hydroxides, carbonates, bicarbonates, hydroxycarboxylates, metasilicates and carbamides, as well as alkali phosphates.
  • the cosmetic agents used in the process according to the invention may furthermore contain all active ingredients, additives and auxiliaries known for such preparations: Washing with a shampoo is unnecessary if a carrier which is highly surfactant-containing was used.
  • the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle.
  • the choice of surfactants depends on the nature of the agent.
  • at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen.
  • These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • the ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5.
  • the ratio is particularly preferably 5: 1 to 1: 2.
  • cationic surfactants are preferably used as surface-active substances or nonionic surfactants selected. Again, a selection of the so-called mild surface-active substances is particularly preferred.
  • Suitable anionic surfactants (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 C atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and Eiweissfettkladensate.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyl taurines, N-alkyl sarcosines, 2-alkylaminopropionic and Alkylaminoessigklaroy each having about 8 to 24 carbon atoms in the alkyl group.
  • ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
  • the alkylene oxide adducts to saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid and the sugar surfactants have proven. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.
  • Cationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention.
  • Anionic surfactants are used in particular when the compositions according to the invention are to be used as shower baths.
  • the surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total amount used in accordance with the invention Medium, used.
  • Emulsifiers which can be used according to the invention are, for example
  • Alkylphenols having 8 to 15 C atoms in the alkyl group having 8 to 15 C atoms in the alkyl group
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols are understood to mean a group of steroids which bind to C-atom 3 of the
  • Steroid scaffold carry a hydroxyl group and both from animal tissue
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol, Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
  • compositions of the invention preferably contain the emulsifiers in quantities of 0.1 to 25 bew.- 0 / o in particular 0.5 to 15 wt .-%, based on the total agent.
  • amphoteric polymers as well as the cationic polymers according to the invention are very particularly preferred polymers.
  • amphoteric polymers includes both those polymers which contain in the molecule both free amino groups and free -COOH or SO 3 H groups and are capable of forming internal salts, as well as zwitterionic polymers which in the molecule have quaternary ammonium groups and -COO or -SO 3 " groups, and those polymers comprising -COOH or SO 3 H groups and quaternary ammonium groups.
  • amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for the sulfonic acid group to be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt , Particularly preferred is the homopolymer of 2-acrylamido-2-methylpropanesulfonic acid, which is commercially available, for example, under the name Rheothik®11-80.
  • the anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the agents according to the invention may contain nonionogenic polymers.
  • the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.
  • Another inventive synergistic active ingredient in the compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).
  • protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids.
  • polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates.
  • the latter include, for example, polyalanine, polyasparagine, polyserine, etc.
  • compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride.
  • ⁇ -amino acids and their derivatives such as ⁇ -alanine, anthranilic acid or hippuric acid can also be used.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are sold, for example, under the trademarks Dehylan® (Cognis), Promois® (Interorgana), Collapuron® (Cognis), Nutrilan® (Cognis), Gelita-Sol® (German Gelatin Factories Stoess & Co), Lexein® (Inolex) and Kerasol® (Croda).
  • vegetable protein hydrolysates such as moringa, soybean, almond, pea, potato and wheat protein hydrolysates are preferred according to the invention.
  • Such products are available, for example, under the trademarks Puricare® LS 9658 (Laboratories Serobiiquess), Gluadin® (Cognis), DiaMin® (Diamalt), Lexein® (Inolex), Hydrosoy® (Croda), Hydrolupin® (Croda), Hydrosesame® (Croda ), Hydrotritium® (Croda) and Crotein® (Croda).
  • Further preferred protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl extracts.
  • the protein hydrolysates (P) are present in the compositions at levels of from 0.001% to 20% by weight, preferably from 0.05% to 15% by weight, and most preferably in amounts of 0, 05 wt .-% up to 5 wt .-% included.
  • compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • Preferred are the Sodium, potassium, calcium, magnesium or ammonium salts, in which the ammonium ion in addition to hydrogen carries one to three C1 to C4 alkyl groups.
  • the sodium salt is most preferred.
  • the amounts used in the inventive compositions are 0.05 to 10 wt .-%, based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt .-%.
  • vitamins are vitamins, provitamins or vitamin precursors.
  • Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • compositions according to the invention may additionally contain antimicrobial compounds.
  • Suitable antimicrobial compounds are, for. B. cationic surfactants such.
  • Good are also the antimicrobial biguanide compounds such.
  • the polyhexamethylene biguanide (Vantocil® IB, ICI) or the 1, 1 ' hexamethylene bis (4-chlorophenyl) biguanide (“chlorhexidine”) in the form of a water-soluble, compatible salt, e.g. In the form of the acetate or gluconate.
  • the antimicrobial 5-amino-hexahydropyrimidines, z for example, the 1, 3-bis (2-ethylhexyl) -5-methyl-5-amino-hexahydropyrimidine ("hexetidine”).
  • suitable antimicrobial agents are the non-cationic, phenolic, antimicrobial substances, in particular the halogenated phenols and diphenyl ethers.
  • Particularly suitable antimicrobial compounds of this type are z. B. the 6,6 ' - methylene-bis- (2-bromo-4-chlorophenol) ("bromochlorophene”) and the 2,4,4 ' trichloro-2 ' hydroxy-diphenyl ether ("Triclosan").
  • agents according to the invention may contain purine and / or derivative (s) of the purine. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.
  • Cosmetic agents preferred according to the invention are characterized in that they contain purine and / or purine derivative (s) of the formula (I) or (II)
  • radicals R 1 , R 2 and R 3 of the formula (I) are selected independently of one another from -H, - OH, -NH 2 , -SH and the radicals R4, R5 and R6 of the formula (II) independently of one another are selected from -H, -CH 3 and -CH 2 -CH 3 are substituted, where the following compounds according to formula (I):
  • Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos, conditioners, hair lotions and / or lotions, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the agent) can be used.
  • compositions according to the invention contain penetration aids and / or swelling agents (M).
  • M penetration aids and / or swelling agents
  • M include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, bicarbonates, Diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol, 1 , 6-hexanediol, 1, 5-pentanediol, 1, 4-
  • a particularly preferred group of swelling agents may be hydantoins. Regardless of whether hydantoin or hydantoin derivative (s) is / are used, amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably.
  • the cosmetic compositions of the invention may contain pharmacologically active substances.
  • pharmacologically active substances are corticosteroids, ⁇ -blockers, estrogens, phytoestrogens, cyproterone acetate, vasodilating substances such as diazoxide, nifedipine and minoxidil, acetylsalicylic acid or salicylic acid. These substances are contained in amounts of from 0.01 to 10% by weight, based in each case on the entire composition.
  • the compositions of the invention contain a bittering agent to prevent swallowing or accidental ingestion.
  • Bitter substances which are soluble in water at 20 ° C. to at least 5 g / l are preferred according to the invention.
  • Quaternary ammonium compounds which contain an aromatic group both in the cation and in the anion are outstandingly suitable as bitter substances.
  • One such compound is benzyldiethyl ((2,6-xylylcarbamoyl) methyl) ammonium benzoate commercially available, for example, under the trade names Bitrex® and Indigo-stin®. This compound is also known by the name Denatonium Benzoate.
  • the bittering agent is contained in the compositions of the invention in amounts of 0.0005 to 0.1 wt .-%, based on the composition. Particular preference is given to amounts of from 0.001 to 0.05% by weight.
  • the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
  • the pH of the compositions according to the invention is preferably between 2 and 12.
  • the adjustment of the pH of the cosmetic compositions according to the invention is carried out using the carboxylic acids or mineral acids such as phosphoric acid, sulfuric acid, etc ..
  • the alkalizing agents are inorganic compounds, preferably hydroxides or ammonia and organic bases, preferably amines and including in particular alkanolamines, can be used.
  • Preferred agents according to the invention additionally comprise, in addition to a cranberry extract, in one cosmetic carrier one of the following active ingredient combinations (xiii) to (xx): (xiii) pantolactone and at least one cationic surfactant, (xiv) pantolactone and at least one cationic polymer, (xv) pantolactone and at least one silicone, (xvi) pantolactone and at least one UV absorber, (xvii) ectoine and at least one cationic surfactant, (xviii) ectoine and at least one cationic polymer,
  • a second subject of the invention is therefore a process for the treatment of keratinic fibers, in which a cosmetic composition containing in a cosmetic carrier a
  • Cranberry extract applied and optionally rinsed again after an exposure time.
  • the exposure time of the cranberry extract is preferably a few seconds to 100 minutes, more preferably a few seconds to 45 minutes and most preferably 1 to 30
  • Carrier at least one oxidizing agent is applied to the hair and after a
  • Cranberry extract applied and optionally rinsed again after an exposure time.
  • cranberry extract as part of a cosmetic
  • a cosmetic carrier By means of containing in a cosmetic carrier additionally at least one oxidizing agent and at least one oxidation dye precursor applied in one step.
  • the oxidative hair dyes of this embodiment are preferably two-component agents.
  • the first component contains in a cosmetic carrier a cranberry extract and at least one oxidation dye precursor.
  • the second component contains at least one oxidizing agent in a cosmetic carrier.
  • Packing unit (kit) provided. Shortly before use, both components are mixed together.
  • the oxidative hair bleaches of this embodiment are preferably two- or three-component agents.
  • the first component contains in a cosmetic carrier a cranberry extract and optionally at least one bleach booster.
  • the bleach booster may also be formulated separately from the cranberry extract, for example in powder form, as an anhydrous paste or an anhydrous oil. Thereby, a three-component agent is obtained.
  • the last component contains at least one oxidizing agent in a cosmetic carrier. All components are preferably packaged separately in each case in a compartment and provided together in a packaging unit (kit). Just before use, all components are mixed together.
  • the multi-component means described above for carrying out the method according to the invention can be provided in a packaging unit.
  • the packaging unit may comprise at least either a container containing the agent of the second subject of the invention or may comprise at least two containers, a first container containing an oxidative cosmetic agent containing at least one oxidizing agent in a cosmetic carrier, a second container containing a cosmetic agent containing in a cosmetic carrier a cranberry extract, and optionally a third container containing at least one bleach booster embedded in a cosmetic carrier. All Kontainer can also be chambers of a multi-chamber container. For the second subject of the invention applies mutatis mutandis what has been said for the first subject of the invention.
  • a third aspect of the present invention is therefore the use, in particular of a cosmetic composition containing a cranberry extract for the treatment of keratin-containing fibers, in particular human hair.
  • the cosmetic agent containing a cranberry extract is used for the repair and / or restructuring of damaged hair.
  • the agent according to the invention is particularly preferably used for the repair and / or restructuring of hair damage caused by oxidation or UV light.
  • the agent according to the invention can be used in a further preferred embodiment for protecting keratin-containing fibers from moisture loss and / or from external influences, such as oxidative treatment or UV radiation.
  • a further preferred embodiment of the present invention comprises the use of the agents according to the invention for improving the shine of keratin-containing fibers, in particular human hair, for improving the combability of keratin-containing fibers, in particular human hair, for improving the feel of keratin-containing fibers, in particular human hair, and for improving the Shaping keratin fibers, especially human hair.
  • the agent according to the invention is used on dyed or tinted keratinic fibers, in particular human hair, for
  • Stenol® 16/18 C 16 . 18 fatty alcohol (INCI name: Cetearyl Alcohol;

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)

Abstract

Un extrait des fruits de la canneberge (Vaccinium macrocarpon) convient remarquablement au traitement de fibres kératiniques, en particulier de cheveux humains, pour l'amélioration de l'humidité dans les fibres, pour la réparation et la restructuration des fibres et pour la protection des fibres vis-à-vis des agents d'oxydation et des rayons ultraviolets, ainsi que pour l'amélioration de la tenue et de l'intensité de la couleur, pour autant qu'il s'agisse, en ce qui concerne les fibres, de cheveux colorés.
PCT/EP2009/050923 2008-02-29 2009-01-28 Produit de traitement capillaire comportant un extrait de canneberge Ceased WO2009106399A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008012068.5 2008-02-29
DE102008012068A DE102008012068A1 (de) 2008-02-29 2008-02-29 Haarbehandlungsmittel mit Cranberry-Extrakt

Publications (1)

Publication Number Publication Date
WO2009106399A1 true WO2009106399A1 (fr) 2009-09-03

Family

ID=40568324

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/050923 Ceased WO2009106399A1 (fr) 2008-02-29 2009-01-28 Produit de traitement capillaire comportant un extrait de canneberge

Country Status (2)

Country Link
DE (1) DE102008012068A1 (fr)
WO (1) WO2009106399A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012159918A1 (fr) * 2011-05-25 2012-11-29 Unilever Plc Produit de coloration pour les cheveux comprenant des ions métalliques et un composant provenant des myrtilles
US8833918B2 (en) 2011-02-17 2014-09-16 Fujifilm Corporation Ink composition, ink set, and image forming method
WO2016096267A1 (fr) * 2014-12-17 2016-06-23 Henkel Ag & Co. Kgaa Agent de traitement capillaire contenant au moins une protéine acide et au moins un sel
SE2250019A1 (en) * 2021-01-14 2022-07-15 Cutrin Oy Hair conditioner composition
WO2022246529A3 (fr) * 2021-05-26 2022-12-29 Sensient Cosmetic Technologies Compositions et procédés de protection contre des allergènes de colorants capillaires oxydatifs

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3122835B1 (fr) * 2021-05-17 2025-04-18 Soc Ind Limousine Dapplication Biologique Extrait deVaccinium macrocarpon et ses effets cosmétiques anti-âge

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980869A (en) * 1997-04-28 1999-11-09 The Procter & Gamble Company Dual phase oral compositions comprising a plant extract from the Ericaceae family
EP1661576A1 (fr) * 2004-11-15 2006-05-31 Pharmatoka SAS Nouvelle utilisation dermatologique et/ou cosmétique d'un extrait végétal
US20060147397A1 (en) * 2002-11-07 2006-07-06 Kose Corporation Composition for preparation for external use on skin and method of using the same
US20070059343A1 (en) * 2005-05-03 2007-03-15 Chinsammy Sridat S Pet life

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
US4122029A (en) 1977-07-27 1978-10-24 Dow Corning Corporation Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant
US4265878A (en) 1979-06-07 1981-05-05 Dow Corning Corporation Antiperspirant stick compositions
JPS5699407A (en) 1980-01-09 1981-08-10 Kao Corp Hair rinse composition
DE3172768D1 (en) 1980-09-05 1985-12-05 Ciba Geigy Ag Mixtures of polymeric high-molecular acrylic quaternary ammonium salts and detergents, their preparation and use in cosmetic formulations
JPS5813700A (ja) 1981-07-17 1983-01-26 花王株式会社 食器用洗浄剤組成物
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
EP0217274A3 (fr) 1985-09-30 1988-06-29 Kao Corporation Composition cosmétique pour les cheveux
DE3708451A1 (de) 1987-03-16 1988-10-06 Henkel Kgaa Zwitterionische polymere und deren verwendung in haarbehandlungsmitteln
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
GB9708182D0 (en) 1997-04-23 1997-06-11 Dow Corning Sa A method of making silicone in water emulsions
DE19738866A1 (de) 1997-09-05 1999-03-11 Henkel Kgaa Schaumarme Tensidmischungen mit Hydroxymischethern
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US5998537A (en) 1998-09-21 1999-12-07 Dow Corning Corporation Emulsions containing ultrahigh viscosity silicone polymers
FR2785183B1 (fr) 1998-11-04 2002-04-05 Oreal COMPOSITION TINCTORIALE CONTENANT UN COLORANT DIRECT CATIONIQUE ET UNE PYRAZOLO-[1,5-a]- PYRIMIDINE A TITRE DE BASE D'OXYDATION, ET PROCEDES DE TEINTURE
DE29908573U1 (de) 1999-05-14 1999-08-05 Wella Ag Haarfärbemittel
DE50102804D1 (de) 2000-07-27 2004-08-12 Ge Bayer Silicones Gmbh & Co Polyammonium-polysiloxan-verbindungen, verfahren zu ihrer herstellung und ihre verwendung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980869A (en) * 1997-04-28 1999-11-09 The Procter & Gamble Company Dual phase oral compositions comprising a plant extract from the Ericaceae family
US20060147397A1 (en) * 2002-11-07 2006-07-06 Kose Corporation Composition for preparation for external use on skin and method of using the same
EP1661576A1 (fr) * 2004-11-15 2006-05-31 Pharmatoka SAS Nouvelle utilisation dermatologique et/ou cosmétique d'un extrait végétal
US20070059343A1 (en) * 2005-05-03 2007-03-15 Chinsammy Sridat S Pet life

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8833918B2 (en) 2011-02-17 2014-09-16 Fujifilm Corporation Ink composition, ink set, and image forming method
WO2012159918A1 (fr) * 2011-05-25 2012-11-29 Unilever Plc Produit de coloration pour les cheveux comprenant des ions métalliques et un composant provenant des myrtilles
WO2016096267A1 (fr) * 2014-12-17 2016-06-23 Henkel Ag & Co. Kgaa Agent de traitement capillaire contenant au moins une protéine acide et au moins un sel
US10780038B2 (en) 2014-12-17 2020-09-22 Henkel Ag & Co. Kgaa Hair treatment agent containing at least one acid protein and at least one salt
SE2250019A1 (en) * 2021-01-14 2022-07-15 Cutrin Oy Hair conditioner composition
SE546848C2 (en) * 2021-01-14 2025-02-25 Cutrin Oy Hair conditioner composition
WO2022246529A3 (fr) * 2021-05-26 2022-12-29 Sensient Cosmetic Technologies Compositions et procédés de protection contre des allergènes de colorants capillaires oxydatifs

Also Published As

Publication number Publication date
DE102008012068A1 (de) 2009-09-10

Similar Documents

Publication Publication Date Title
EP2262473A2 (fr) Produit pour le traitement des cheveux, avec de l'extrait de plaquebière
EP2897576B1 (fr) Moyen de traitement de fibres kératiniques, contenant des aminosilicones spécifiques, des acides et des colorants directs
WO2011009759A2 (fr) Utilisation de dihydroquercétine et d'au moins un acide aminé pour influencer positivement le processus de pigmentation naturel
DE102016200688A1 (de) Keratinfaserschonende Mittel und Verfahren zur oxidativen Haarfärbung
DE102016209468A1 (de) Haar schonende Mittel und Verfahren zur oxidativen Haarfärbung oder Blondierung mit ausgewählten Dicarbonsäuren
EP3079653A1 (fr) Procédé destiné au lissage, au conditionnement et à la coloration de cheveux, notamment de cheveux très frisés
WO2009106399A1 (fr) Produit de traitement capillaire comportant un extrait de canneberge
EP2608848B1 (fr) Décoloration avec un prétraitement réducteur
DE102020209041A1 (de) "Mittel zur Behandlung von keratinischen Fasern mit Komplexbildner und Aminosäure und/oder Proteinhydrolysat"
EP1690524A2 (fr) Dérivés de cellulose cationique dans des compositions cosmétiques
WO2015086230A1 (fr) Lissage des cheveux à l'acide glyoxylique
EP1404286A1 (fr) Agent de soin capillaire comprenant des betaines
WO2016139125A1 (fr) Produits cosmétiques contenant une substance bioactive et un dipeptide
EP3644946B1 (fr) Procédé pour éclaircir les cheveux contenant des acides oxo-carboxyliques spéciaux
EP0648104B1 (fr) Agents de traitement capillaire
EP3229910A1 (fr) Produits cosmétiques comprenant un protéolipide et de la méthylméthionine
WO2009109426A1 (fr) Produit de traitement capillaire à l'extrait de goji
WO2009109425A1 (fr) Produit de traitement capillaire à l'extrait d'açaï
DE102012215046A1 (de) Lycopin zur Stimulierung der Keratinsynthese
WO2015086269A1 (fr) Procédé et kit pour lisser et colorer les cheveux avec une couverture des cheveux blancs et une résistance au lavage améliorées
EP2810697A1 (fr) Produit pour la croissance des cheveux contenant de l'extrait de Leontopodium
DE102015216687A1 (de) "Leistungsstarke Haarbehandlungsmittel mit einem Proteolipid und einem Magnesiumsalz"
EP0742709B1 (fr) Complexe de principes actifs pour agents de soins capillaires
EP2061426A1 (fr) Extrait de racine issu de harpagophytum pour stimuler la pousse des cheveux
DE102024203174A1 (de) Haarpflegeshampoo enthaltend Polylysin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09715786

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09715786

Country of ref document: EP

Kind code of ref document: A1